Page last updated: 2024-10-31

methylphenidate and Hypomania

methylphenidate has been researched along with Hypomania in 2 studies

Methylphenidate: A central nervous system stimulant used most commonly in the treatment of ATTENTION DEFICIT DISORDER in children and for NARCOLEPSY. Its mechanisms appear to be similar to those of DEXTROAMPHETAMINE. The d-isomer of this drug is referred to as DEXMETHYLPHENIDATE HYDROCHLORIDE.
methylphenidate : A racemate comprising equimolar amounts of the two threo isomers of methyl phenyl(piperidin-2-yl)acetate. A central stimulant and indirect-acting sympathomimetic, is used (generally as the hydrochloride salt) in the treatment of hyperactivity disorders in children and for the treatment of narcolepsy.
methyl phenyl(piperidin-2-yl)acetate : A amino acid ester that is methyl phenylacetate in which one of the hydrogens alpha to the carbonyl group is replaced by a piperidin-2-yl group.

Research Excerpts

ExcerptRelevanceReference
"Novel and effective treatments for mania are needed, and well‑validated animal models are important to reach this goal."1.72Effect of repeated sodium valproate and topiramate administration on mania‑like behaviors induced by methylphenidate in mice. ( Andreatini, R; Gonçalves, PS; Monteiro Pereira, VC; Pesquero, BO; Valentin, DT, 2022)

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's2 (100.00)2.80

Authors

AuthorsStudies
Gonçalves, PS1
Pesquero, BO1
Valentin, DT1
Monteiro Pereira, VC1
Andreatini, R1
Friedrich, B1
Bridler, R1

Other Studies

2 other studies available for methylphenidate and Hypomania

ArticleYear
Effect of repeated sodium valproate and topiramate administration on mania‑like behaviors induced by methylphenidate in mice.
    Acta neurobiologiae experimentalis, 2022, Volume: 82, Issue:4

    Topics: Animals; Antimanic Agents; Central Nervous System Stimulants; Mania; Methylphenidate; Mice; Topirama

2022
    Praxis, 2020, Volume: 109, Issue:16

    Topics: Attention Deficit Disorder with Hyperactivity; Bipolar Disorder; Humans; Mania; Methylphenidate; Moo

2020